A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging
NCT06271928
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Aging
Interventions
DRUG:
Yijing Keli
Sponsor
Tongji Hospital